[-] Show simple item record

dc.contributor.authorGallimore, Caseyeng
dc.date.issued2008-12eng
dc.description.abstractWhile some small differences have been found between agents, selective serotonin reuptake inhibitors (SSRIs) and non-SSRI second-generation antidepressants generally have similar efficacy and discontinuation rates when used to treat depression. However, side effect profiles differ by agent: more blood pressure elevation with venlafaxine, more weight gain with mirtazapine, and less sexual dysfunction with bupropion. (SOR A, based on systematic reviews and meta-analyses.)eng
dc.identifier.citationEvidence Based Practice 11(12): 06-07.eng
dc.identifier.urihttp://hdl.handle.net/10355/7402eng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofEvidence Based Practice 11(12): 06-07.eng
dc.relation.ispartofcollectionEvidence Based Practice, 2008eng
dc.relation.ispartofseriesHelp Desk Answers (Evidence Based Practice, 2008)eng
dc.subject.lcshDrugs -- Side effectseng
dc.subject.lcshDepression, Mental -- Treatmenteng
dc.titleWhat is the relative effectiveness and safety of second-generation antidepressants?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record